Crestchem Board of Directors
Get the latest insights into the leadership at Crestchem. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Dipak Narendraprasad Patel | Promoter |
| Mr. Nitinkumar Shantilal Shah | Non Exe. & Ind. Director |
| Mrs. Rinkal Maulik Jasani | Non Exe. Women Independent Director |
| Mrs. Priyankaben M Patel | Ind. Non-Executive Director |
| Mr. Jignesh A Shah | Ind. Non-Executive Director |
| Mr. Nirmit Dipak Patel | Executive Director |
Crestchem Share price
CRSTCHM
124.7
2.85 (2.34%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
125.00
Today's Low
120.60
52 Week Low
114.00
52 Week High
350.00
The current prices are delayed, login to your account for live prices
LoginCrestchem FAQs
The board at Crestchem consists of experienced professionals, including Mr. Dipak Narendraprasad Patel , Mr. Nitinkumar Shantilal Shah , and others, overseeing the company’s strategic and corporate governance.
Directors at Crestchem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Dipak Narendraprasad Patel is the current chairman at Crestchem.
Executive directors at Crestchem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Crestchem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Crestchem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.